85 related articles for article (PubMed ID: 19833195)
1. Assessment of a recombinant androgen receptor binding assay: initial steps towards validation.
Freyberger A; Weimer M; Tran HS; Ahr HJ
Reprod Toxicol; 2010 Aug; 30(1):2-8. PubMed ID: 19833195
[TBL] [Abstract][Full Text] [Related]
2. Assessment of a robust model protocol with accelerated throughput for a human recombinant full length estrogen receptor-alpha binding assay: protocol optimization and intralaboratory assay performance as initial steps towards validation.
Freyberger A; Wilson V; Weimer M; Tan S; Tran HS; Ahr HJ
Reprod Toxicol; 2010 Aug; 30(1):50-9. PubMed ID: 20074635
[TBL] [Abstract][Full Text] [Related]
3. Screening for (anti)androgenic properties using a standard operation protocol based on the human stably transfected androgen sensitive PALM cell line. First steps towards validation.
Freyberger A; Witters H; Weimer M; Lofink W; Berckmans P; Ahr HJ
Reprod Toxicol; 2010 Aug; 30(1):9-17. PubMed ID: 19836445
[TBL] [Abstract][Full Text] [Related]
4. Endocrine toxicology--contributions of in vitro methods to the 3R concept.
Freyberger A; Scholz G
ALTEX; 2004; 21 Suppl 3():20-7. PubMed ID: 15057405
[TBL] [Abstract][Full Text] [Related]
5. Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds.
van der Burg B; Winter R; Man HY; Vangenechten C; Berckmans P; Weimer M; Witters H; van der Linden S
Reprod Toxicol; 2010 Aug; 30(1):18-24. PubMed ID: 20438827
[TBL] [Abstract][Full Text] [Related]
6. The assessment of estrogenic or anti-estrogenic activity of chemicals by the human stably transfected estrogen sensitive MELN cell line: results of test performance and transferability.
Witters H; Freyberger A; Smits K; Vangenechten C; Lofink W; Weimer M; Bremer S; Ahr PH; Berckmans P
Reprod Toxicol; 2010 Aug; 30(1):60-72. PubMed ID: 20362049
[TBL] [Abstract][Full Text] [Related]
7. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B
Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor activities of p,p'-DDE, fenvalerate and phoxim detected by androgen receptor reporter gene assay.
Xu LC; Sun H; Chen JF; Bian Q; Song L; Wang XR
Toxicol Lett; 2006 Jan; 160(2):151-7. PubMed ID: 16125883
[TBL] [Abstract][Full Text] [Related]
9. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS
Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690
[TBL] [Abstract][Full Text] [Related]
10. Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor.
Fang H; Tong W; Branham WS; Moland CL; Dial SL; Hong H; Xie Q; Perkins R; Owens W; Sheehan DM
Chem Res Toxicol; 2003 Oct; 16(10):1338-58. PubMed ID: 14565775
[TBL] [Abstract][Full Text] [Related]
11. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.
Doesburg P; Kuil CW; Berrevoets CA; Steketee K; Faber PW; Mulder E; Brinkmann AO; Trapman J
Biochemistry; 1997 Feb; 36(5):1052-64. PubMed ID: 9033395
[TBL] [Abstract][Full Text] [Related]
12. Integrated molecule-format bioluminescent probe for visualizing androgenicity of ligands based on the intramolecular association of androgen receptor with its recognition Peptide.
Kim SB; Awais M; Sato M; Umezawa Y; Tao H
Anal Chem; 2007 Mar; 79(5):1874-80. PubMed ID: 17269793
[TBL] [Abstract][Full Text] [Related]
13. The OECD program to validate the rat Hershberger bioassay to screen compounds for in vivo androgen and antiandrogen responses: phase 2 dose-response studies.
Owens W; Gray LE; Zeiger E; Walker M; Yamasaki K; Ashby J; Jacob E
Environ Health Perspect; 2007 May; 115(5):671-8. PubMed ID: 17520051
[TBL] [Abstract][Full Text] [Related]
14. Development and standardization of a simple binding assay for the detection of compounds with affinity for the androgen receptor.
Freyberger A; Ahr HJ
Toxicology; 2004 Feb; 195(2-3):113-26. PubMed ID: 14751668
[TBL] [Abstract][Full Text] [Related]
15. Partial agonist/antagonist properties of androstenedione and 4-androsten-3beta,17beta-diol.
Chen F; Knecht K; Leu C; Rutledge SJ; Scafonas A; Gambone C; Vogel R; Zhang H; Kasparcova V; Bai C; Harada S; Schmidt A; Reszka A; Freedman L
J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):247-57. PubMed ID: 15336702
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a rapid in vitro androgen receptor transcriptional activation assay using AR-EcoScreen cells.
Araki N; Ohno K; Takeyoshi M; Iida M
Toxicol In Vitro; 2005 Apr; 19(3):335-52. PubMed ID: 15713541
[TBL] [Abstract][Full Text] [Related]
17. Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context.
Simon S; Mueller SO
Toxicology; 2006 Mar; 220(2-3):90-103. PubMed ID: 16413649
[TBL] [Abstract][Full Text] [Related]
18. 7alpha-Iodo and 7alpha-fluoro steroids as androgen receptor-mediated imaging agents.
Labaree DC; Hoyte RM; Nazareth LV; Weigel NL; Hochberg RB
J Med Chem; 1999 Jun; 42(11):2021-34. PubMed ID: 10354410
[TBL] [Abstract][Full Text] [Related]
19. A comparison of in vitro and in vivo EDSTAC test battery results for detecting antiandrogenic activity.
Charles GD; Kan HL; Schisler MR; Bhaskar Gollapudi B; Sue Marty M
Toxicol Appl Pharmacol; 2005 Jan; 202(1):108-20. PubMed ID: 15589981
[TBL] [Abstract][Full Text] [Related]
20. Anabolic-androgenic steroid interaction with rat androgen receptor in vivo and in vitro: a comparative study.
Feldkoren BI; Andersson S
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):481-7. PubMed ID: 15876413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
